1. Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts;
2. CAUSALab, Departments of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts;
3. Division of Global Health Equity, Brigham and Women’s Hospital, Boston, Massachusetts;
4. Partners in Health, Boston, Massachusetts;
5. Interactive Research and Development Global, Singapore, Singapore;
6. Field Epidemiology Department, Epicentre, Paris, France;
7. National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia;
8. Unidad de Tuberculosis, Hospital Nacional Dos de Mayo, Lima, Peru;
9. Instituto de Investigaciones en Ciencias Biomedicas, Universidad Ricardo Palma, Lima, Peru;
10. Interactive Research and Development, Dhaka, Bangladesh;
11. Médecins sans Frontières, Yangon, Myanmar;
12. Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;
13. Indus Hospital and Health Network, Karachi, Pakistan;
14. Médecins sans Frontières, Yerevan, Armenia;
15. Zanmi Lasante, Port-au-Prince, Haiti;
16. National Core Research Group, Stop TB Partnership, Islamabad, Pakistan;
17. Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Minsk, Belarus;
18. Astana City Center of Phthisiopulmonology, Astana, Kazakhstan;
19. Partners in Health, Maseru, Lesotho;
20. GHESKIO, Port-au-Prince, Haiti;
21. Interactive Research and Development, Durban, South Africa;
22. Medical Department, Médecins sans Frontières, Paris, France; and
23. Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom